Advertisement

Extraction and Purification of F1 Capsule Antigen from Y. pestis

  • Xiaoyi Wang
Protocol
Part of the Springer Protocols Handbooks book series (SPH)

Abstract

In this chapter, I describe a simple and efficient strategy to obtain purified F1 antigen from Yersinia pestis. Yersinia pestis strain EV76 is inoculated into brain–heart infusion medium containing sterile glass beads and then incubated at 37 °C for 72 h with shaking at 175 rpm. The supernatant is collected by centrifugation and then precipitated with 40% (w/v) saturated ammonium sulfate. The protein pellet is collected by centrifugation, redissolved in 0.01 M phosphate-buffered saline (pH 7.2), and then precipitated with 25% (w/v) saturated ammonium sulfate. The supernatant is precipitated with 5% saturated ammonium sulfate. Finally, highly purified F1 protein is obtained using a Sephacryl S-200HR column. The F1 protein is quantified based on the area and the intensity of its band in a sodium dodecyl sulfate–polyacrylamide gel stained with Coomassie Brilliant Blue. The F1 protein content is determined using a bicinchoninic acid assay. The purity of the F1 antigen is determined by high-performance liquid chromatography, and Western blotting is used to confirm the specificity of the F1 antigen using a specific monoclonal antibody against the F1 antigen.

Key words

Capsule F1 antigen Purification Yersinia pestis 

References

  1. 1.
    Cornelis GR, Van Gijsegem F (2000) Assembly and function of type III secretory systems. Annu Rev Microbiol 54:735–774CrossRefPubMedGoogle Scholar
  2. 2.
    Brubaker RR (2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 71:3673–3681CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Cornelis GR (2002) The Yersinia Ysc-Yop ‘type III’ weaponry. Nat Rev Mol Cell Biol 3:742–752CrossRefPubMedGoogle Scholar
  4. 4.
    Lathem WW, Price PA, Miller VL, Goldman WE (2007) A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315:509–513CrossRefPubMedGoogle Scholar
  5. 5.
    Zimbler DL, Schroeder JA, Eddy JL, Lathem WW (2015) Early emergence of Yersinia pestis as a severe respiratory pathogen. Nat Commun 6.  https://doi.org/10.1038/ncomms8487
  6. 6.
    Felek S, Muszynski A, Carlson RW, Tsang TM, Hinnebusch BJ, Krukonis ES (2010) Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. Infect Immun 78:1163–1175CrossRefPubMedGoogle Scholar
  7. 7.
    Du Y, Rosqvist R, Forsberg A (2002) Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 70(3):1453–1460CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Karlyshev AV, Galyov EE, Abramov VM, Zav’yalov VP (1992) Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett 305(1):37–40CrossRefPubMedGoogle Scholar
  9. 9.
    Smiley ST (2007) Cell-mediated defense against Yersinia pestis infection. Adv Exp Med Biol 603:376–386CrossRefPubMedGoogle Scholar
  10. 10.
    Sabhnani L, Rao DN (2000) Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol Med Microbiol 27(2):155–162CrossRefPubMedGoogle Scholar
  11. 11.
    Simpson WJ, Thomas RE, Schwan TG (1990) Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am J Trop Med Hyg 43(4):389–396CrossRefPubMedGoogle Scholar
  12. 12.
    Chanteau S, Rahalison L, Ratsitorahina M, Mahafaly RM, Boisier P, O’Brien T, Aldrich J, Keleher A, Morgan C et al (2000) Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick. Int J Med Microbiol 290(3):279–283CrossRefPubMedGoogle Scholar
  13. 13.
    Andrews GP, Heath DG, Anderson GW Jr, Welkos SL, Friedlander AM (1996) Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 64(6):2180–2187PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Xiaoyi Wang
    • 1
  1. 1.Beijing Institute of Microbiology and EpidemiologyBeijingChina

Personalised recommendations